Hereditary Baldness: Is It in Your Genes?

Is Baldness Hereditary?

Alopecia, the medical term for hair loss, manifests in various forms and can have diverse origins. This phenomenon can be temporary or permanent, localised or generalised. It may result from stress, nutritional deficiencies, autoimmune diseases or, more frequently, a genetic predisposition (Sadasivam et al., 2024).

Hereditary vs Androgenetic Alopecia: What’s the Difference?

Androgenetic alopecia is a specific form of hair loss that combines two key elements: a favourable genetic background and sensitivity to androgen hormones. These hormones, primarily male but also present in reduced quantities in women, interact with genetically predisposed hair follicles, progressively triggering their miniaturisation (Lolli et al., 2017).

This complex mechanism explains why some people develop baldness while others, even when exposed to the same hormone levels, maintain their full head of hair. Research has shown that androgenetic alopecia is a polygenic condition, involving the interaction of multiple genes (Sadasivam et al., 2024).

Who Passes on the Baldness Gene?

The genetic transmission of baldness follows a complex pattern involving several genes. The X chromosome, inherited from the mother, carries a major gene influencing baldness in men. This gene, called the androgen receptor (AR), plays a crucial role in the development of androgenetic alopecia (Hillmer et al., 2005).

However, other genes located on non-sex chromosomes also contribute to the development of alopecia. Notably, genes regulating enzymes such as 5-alpha reductase and aromatase impact hormone transformation in the scalp.

It’s the combination of these different genetic variations that determines the predisposition to early baldness. Recent studies have identified several genetic loci associated with an increased risk of androgenetic alopecia, highlighting the complex and polygenic nature of this condition (Lolli et al., 2017).

What’s the Likelihood of Experiencing Baldness?

The incidence of androgenetic alopecia increases significantly with age, particularly in men of European descent. Statistics show a steady progression: about 20% of men are affected at 20 years old, 30% at 30, 40% at 40, and so on. This regular progression underscores the growing impact of this phenomenon with age.

In women, although less frequent, androgenetic alopecia affects about one in five women around 40 and one in four around 60. Nevertheless, it represents 80% of cases of lasting hair loss in women. It’s important to note that the manifestation and progression of androgenetic alopecia can vary considerably between individuals, due to the complexity of genetic and environmental factors involved (Lolli et al., 2017).

What Are the Symptoms of Hereditary Baldness?

Hereditary baldness manifests progressively and generally follows characteristic patterns. The first signs can appear as early as adolescence or early adulthood. Hair loss often begins subtly, with a gradual thinning of certain areas of the scalp, particularly at the temples and crown.

How Does Hereditary Baldness Progress in Men?

The Norwood-Hamilton scale is the reference tool for assessing the progression of male baldness. This scale defines seven stages of evolution, ranging from an intact hairline to extensive hair loss. It allows healthcare professionals to monitor the progression of baldness and adapt treatments accordingly.

• Stage 1: No notable hair loss.

• Stage 2: Slight recession of the hairline at the temples.

• Stage 3: Appearance of more visible bald spots on the temples.

• Stage 4: Significant hair loss on the crown, while preserving a band of hair on the sides.

• Stage 5: Reduction of the hair band, progressively linking the bald areas of the temples and crown.

• Stage 6: Merging of bald areas with significant density loss.

• Stage 7: Near-total baldness, leaving only a thin crown of hair.

Why Are the Frontal and Temporal Areas Affected First?

Hereditary baldness first manifests in the frontal and temporal areas due to the increased sensitivity of hair follicles to dihydrotestosterone (DHT), a derivative of androgens. These areas are genetically programmed to react more strongly to this hormone, which explains their early vulnerability. Research has shown that genetic variations in the androgen receptor gene (AR) play a crucial role in this differential sensitivity (Hillmer et al., 2005).

How Does Hereditary Baldness Progress in Women?

Female alopecia follows the Ludwig scale, which comprises three distinct stages:

• Stage I: Slight thinning on the top of the scalp, mainly visible at the parting line, which gradually widens.

• Stage II: More pronounced thinning at the vertex, the parting becomes wider, and hair density decreases significantly. Hair becomes finer.

• Stage III: Significant loss across the entire top of the scalp, while generally preserving the frontal hairline. The thinning area is visible and extensive, but unlike men, women usually retain their frontal hairline.

Unlike male baldness, the pattern of loss in women is more diffuse and generally preserves the frontal hairline, concentrating on the top and central part of the scalp. This difference in pattern between men and women is partly explained by variations in the expression of genes related to androgens and their metabolism (Lolli et al., 2017).

How to Prevent Hereditary Baldness?

While it’s impossible to alter one’s genetic predisposition, several preventive measures can be adopted to slow the progression of hereditary baldness.

A balanced diet, rich in essential vitamins and minerals, can contribute to maintaining hair health.

Stress management, avoiding aggressive hair treatments, and adopting good hair hygiene are also important. It’s crucial to understand that these measures can help maintain overall hair health, but cannot completely counteract the effects of underlying genetic factors (Sadasivam et al., 2024).

What Solutions Are There to Combat Hereditary Baldness?

In the face of hereditary baldness, numerous therapeutic solutions have been developed in recent years.

From drug treatments to advanced surgical techniques, the available arsenal has considerably expanded. These different approaches, whether preventive or curative, now allow for slowing the progression of alopecia and even restoring natural hair.

The choice of treatment depends on several factors, notably the stage of baldness and the patient’s expectations.

Medicinal Solutions

Medicinal solutions constitute the first line of treatment against hereditary baldness. Two main medications have proven their effectiveness and are approved for the treatment of androgenetic alopecia:

• Finasteride, administered orally, acts by blocking the conversion of testosterone to DHT (dihydrotestosterone), the hormone responsible for the miniaturisation of hair follicles. This treatment is intended only for men and requires a medical prescription.
• Minoxidil, available in solution or foam for local application, stimulates scalp microcirculation and lengthens the growth phase of hair. It can be used by both men and women.

These treatments have shown significant effectiveness in slowing the progression of androgenetic alopecia and, in some cases, in stimulating hair regrowth (Lolli et al., 2017).

Other complementary treatments may also be recommended:

• Targeted food supplements (biotin, zinc, iron)
• Scalp mesotherapy
• Platelet-rich plasma (PRP)

Hair Transplantation

Advances in hair medicine have made hair transplantation a durable and effective solution against baldness. Two modern techniques currently dominate the field: Sapphire FUE and DHI (Direct Hair Implantation):

• Sapphire FUE: Follicular Unit Extraction (FUE) Sapphire is a technique that involves extracting hair follicles one by one from a donor area (usually the back of the head). What differentiates this method is the use of sapphire blades to make precise incisions and minimise scarring. The grafts are then implanted in the bald areas with a natural orientation. This technique is appreciated for its natural results and rapid recovery time.

• DHI (Direct Hair Implantation): DHI is an advanced technique that allows direct implantation of extracted follicles without having to create implantation channels beforehand. The grafts are inserted using an implanter shaped like a pen, called a Choi pen, offering optimal control over the angle, depth, and direction of the implants. This increased precision allows for an even more natural and homogeneous result.

Turkey has established itself as a reference destination for hair transplantation, combining medical expertise and cost advantages. In Istanbul, Dr Emrah Cinik’s clinic stands out for its excellence. A renowned hair surgeon, Dr Cinik combines technical expertise with a personalised approach for each patient. His clinic uses the most advanced techniques such as Sapphire FUE and DHI, guaranteeing natural and lasting results.

The experienced medical team, state-of-the-art equipment, and rigorous post-operative follow-up ensure optimal care. For international patients, the clinic offers comprehensive packages including transport and accommodation, making treatment in Turkey particularly attractive for UK residents seeking hair restoration solutions.

Sources

Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freudenberg, J., Brockschmidt, F. F., Flaquer, A., Freudenberg-Hua, Y., Jamra, R. A., Metzen, C., Heyn, U., Schweiger, N., Betz, R. C., Blaumeiser, B., Hampe, J., Schreiber, S., Schulze, T. G., Hennies, H. C., Schumacher, J., … Nöthen, M. M. (2005). Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia. American Journal of Human Genetics, 77(1), 140-148. https://doi.org/10.1086/431425

Lolli, F., Pallotti, F., Rossi, A., Fortuna, M. C., Caro, G., Lenzi, A., Sansone, A., & Lombardo, F. (2017). Androgenetic alopecia: A review. Endocrine, 57(1), 9-17. https://doi.org/10.1007/s12020-017-1280-y

Sadasivam, I. P., Sambandam, R., Kaliyaperumal, D., & Dileep, J. E. (2024). Androgenetic Alopecia in Men: An Update On Genetics. Indian Journal of Dermatology, 69(3), 282. https://doi.org/10.4103/ijd.ijd_729_23